HardIndigenous HealthSecondary prophylaxis for rheumatic heart diseaseau-amcau-racgp
A 16-year-old Aboriginal girl from a remote community has a history of rheumatic fever and moderate rheumatic mitral regurgitation. She has been receiving secondary prophylaxis with intramuscular benzathine benzylpenicillin G every 4 weeks but has missed her last two injections. She remains in the community with limited access to specialist care. What is the most appropriate strategy to reduce her risk of recurrent rheumatic fever?